Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shaun Rowe

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Thrombolysis|November 17, 2021
Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patientsCaitlyn Whitaker, Amanda McKinney, Reagan Bollig, et al.
American Journal of Pharmaceutical Education|July 5, 2012
Pharmacy student knowledge retention after completing either a simulated or written patient caseShaunta' M Ray, Douglas R Wylie, A Shaun Rowe, et al.
Surgical Infections|February 8, 2022
Antibiotic Prophylaxis and Incidence of Infection with External Ventricular Drains and Intra-Cranial Pressure MonitorsMary N Walton, Leslie A Hamilton, Sonia J Kennedy, et al.
Critical Care Medicine|March 5, 2015
Management of apixaban-associated subdural hematoma: a case report on the use of factor eight inhibitor bypassing activityDerrick R Rinehart, Nicholas R Lockhart, Leslie A Hamilton, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|November 17, 2023
Activated Prothrombin Complex Concentrates for the Treatment of Factor Xa Inhibitor-Associated Spontaneous Intracerebral HemorrhageA Shaun Rowe, Leslie A Hamilton, Jacob A Barber, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 2023
Predictive value of methicillin-resistant staphylococcus aureus nasal swab in patients with COVID-19 pneumonia and secondary bacterial pneumoniaA Shaun Rowe, Brandon Hawkins, Megan Doyle McClam, et al.
Neurocritical Care|May 27, 2022
Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain InjuriesGrace E Cooksey, Leslie A Hamilton, James C McMillen, et al.
Critical Care Medicine|March 3, 2018
Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist ReversalA Shaun Rowe, Scott K Dietrich, John W Phillips, et al.
The Annals of Pharmacotherapy|February 26, 2024
Incidence of Hypertriglyceridemia in Patients on Propofol, Clevidipine, or BothChristopher B Johns, Travis W Fleming, Skyler R Brown, et al.
Intensive & Critical Care Nursing|July 8, 2025
Evaluation of alcohol withdrawal assessment in mechanically ventilated patients in a trauma/surgical intensive care unitZachary Smith, Amanda L McKinney, Reagan Bollig, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Thrombolysis|November 17, 2021
Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patientsCaitlyn Whitaker, Amanda McKinney, Reagan Bollig, et al.
American Journal of Pharmaceutical Education|July 5, 2012
Pharmacy student knowledge retention after completing either a simulated or written patient caseShaunta' M Ray, Douglas R Wylie, A Shaun Rowe, et al.
Surgical Infections|February 8, 2022
Antibiotic Prophylaxis and Incidence of Infection with External Ventricular Drains and Intra-Cranial Pressure MonitorsMary N Walton, Leslie A Hamilton, Sonia J Kennedy, et al.
Critical Care Medicine|March 5, 2015
Management of apixaban-associated subdural hematoma: a case report on the use of factor eight inhibitor bypassing activityDerrick R Rinehart, Nicholas R Lockhart, Leslie A Hamilton, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|November 17, 2023
Activated Prothrombin Complex Concentrates for the Treatment of Factor Xa Inhibitor-Associated Spontaneous Intracerebral HemorrhageA Shaun Rowe, Leslie A Hamilton, Jacob A Barber, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 2023
Predictive value of methicillin-resistant staphylococcus aureus nasal swab in patients with COVID-19 pneumonia and secondary bacterial pneumoniaA Shaun Rowe, Brandon Hawkins, Megan Doyle McClam, et al.
Neurocritical Care|May 27, 2022
Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain InjuriesGrace E Cooksey, Leslie A Hamilton, James C McMillen, et al.
Critical Care Medicine|March 3, 2018
Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist ReversalA Shaun Rowe, Scott K Dietrich, John W Phillips, et al.
The Annals of Pharmacotherapy|February 26, 2024
Incidence of Hypertriglyceridemia in Patients on Propofol, Clevidipine, or BothChristopher B Johns, Travis W Fleming, Skyler R Brown, et al.
Intensive & Critical Care Nursing|July 8, 2025
Evaluation of alcohol withdrawal assessment in mechanically ventilated patients in a trauma/surgical intensive care unitZachary Smith, Amanda L McKinney, Reagan Bollig, et al.
Pageof 5